With its blockbuster hopes in question after a catastrophic patent loss, Amarin’s Vascepa continues to pique investigators’ interest over how exactly it cuts patients’ cardiovascular risks. New data from an investigator-sponsored imaging study could provide a clue.
Vascepa cut patients’ coronary plaque by 17% over placebo in an 18-month imaging study investigating the mechanism of action behind the pill’s FDA-approved CV risk benefits, according to late-breaking science presented Saturday at the European Society of Cardiology’s virtual annual meeting.
Patients treated with a daily 4-milligram dose of Vascepa after statins saw a significant reduction in plaque levels, a potential clue behind how the fish-oil derivative helps cut the risk of major cardiovascular events in patients with abnormally high triglycerides and preexisting cardiovascular disease.
Fierce Webinar
Leveraging Innovative Technologies, Best Practices and Strategies to Accelerate Biologics Development and Commercialization
Learn practical implementation of innovative technologies and solutions such as multi-attribute method, modernized cell line development workflow using high-yield cell lines and automated systems, next generation purification resins. The webinar will also showcase best practices and strategies such as phase appropriate quality systems, and integrated drug substance – drug product solutions that leverage standardized technology platforms.
The 18-month findings followed nine-month interim data from the Lundquist Institute study presented in November.
Vascepa notched an FDA approval in December to include its heart-helping benefits on its label, which at the time marked a potential blockbuster label expansion. The agency based its review on Amarin’s Reduce-It outcomes study, which showed that Vascepa cut the risk of major CV events by 25% over placebo.
One of the lingering unknowns from that trial—the effect of a mineral oil placebo, rather than a traditional placebo, on patient outcomes—was addressed in the Evaporate study, which found the mineral oil pill had no significant effect at reducing arterial plaque over another placebo.
twisted family secrets full movie limpiando culo snigdha sinha video anyxvideos.com sex slave full video view here ksb besaba com katrina reyal sex garden on house wife rape 1st sex young xnxx-br.com bd bdsexvideo sasur bhou sex romance bluepornsex video xxx vide0 gan czech teen swallow money گایدن افقانی anushka sharma ki video vdeo xxx japaeb fetishwife clare